Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspective

Cancer Cell. 2021 Mar 8;39(3):394-406.e4. doi: 10.1016/j.ccell.2020.12.022. Epub 2021 Jan 21.

Abstract

Talimogene laherparepvec (T-VEC) is a genetically modified herpes simplex 1 virus (HSV-1) approved for cancer therapy. We investigate its effect on the clinical, histological, single-cell transcriptomic, and immune repertoire level using repeated fine-needle aspirates (FNAs) of injected and noninjected lesions in primary cutaneous B cell lymphoma (pCBCL). Thirteen patients received intralesional T-VEC, 11 of which demonstrate tumor response in the injected lesions. Using single-cell sequencing of the FNAs, we identify the malignant population and separate three pCBCL subtypes. Twenty-four hours after the injection, we detect HSV-1T-VEC transcripts in malignant and nonmalignant cells of the injected lesion but not of the noninjected lesion. Oncolytic virotherapy results in a rapid eradication of malignant cells. It also leads to interferon pathway activation and early influx of natural killer cells, monocytes, and dendritic cells. These events are followed by enrichment in cytotoxic T cells and a decrease of regulatory T cells in injected and noninjected lesions.

Keywords: T-VEC-induced innate and adaptive immunity; nonspecific cell infection; oncolytic virotherapy; primary cutaneous B cell lymphoma; single-cell RNA sequencing; single-cell immune repertoire profiling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biological Products / immunology
  • Dendritic Cells / immunology
  • Female
  • Herpesvirus 1, Human / immunology
  • Humans
  • Killer Cells, Natural / immunology
  • Lymphoma, B-Cell / immunology*
  • Lymphoma, B-Cell / therapy*
  • Lymphoma, B-Cell / virology
  • Male
  • Middle Aged
  • Monocytes / immunology
  • Oncolytic Virotherapy / methods
  • Oncolytic Viruses / immunology*
  • Single-Cell Analysis
  • T-Lymphocytes, Cytotoxic / immunology
  • T-Lymphocytes, Regulatory / immunology

Substances

  • Biological Products
  • talimogene laherparepvec